CGB 0.00% 2.1¢ cann global limited

Ann: Pharmocann Partnership Operational Update, page-3

  1. 4,751 Posts.
    lightbulb Created with Sketch. 358

    How is this not a Price sensitive announcement.



    Cann Global, in discussion with its Medical Cannabis Licensing management team partners, Medcan Australia, and manufacturing partner Bio Health, will begin to make preparations for the production and manufacture of the new range of Pharmaceuticals which will be marketed under the Cann Global label for sale in Australia and for export to Asia and International markets.

 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.